DRKS00020788暂停未知
The impact of dietary cholesterol and the gut microbiota on the intestinal lipid resorption and the systemic lipid metabolism - Cholipid
Technische Universität München, Wissenschaftszentrum Weihenstephan, Lehrstuhl für Molekulare Ernährungsmedizin0 个研究点目标入组 10 人开始时间: 2020年2月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Age 20 to 40
- •written consent
- •BMI 18-35 kg/m²
- •Women and Men (1:1)
排除标准
- •Missing written consent
- •active smokers
- •chronic diseases like:
- •chronic infection (e.g. HIV)
- •diagnosed liver diseases (e.g. HBV,HCV)
- •diagnosed diabetes mellitus
- •required to undergo dialysis
- •pregnant or breastfeeding women
- •active participation in other interventionstudies
研究者
相似试验
已完成
不适用
Effects of the gut flora on serum LDL cholesterol concentrations in slightly hypercholesterolemic subjectshypercholesterolemia / increased serum cholesterol concentration10013317NL-OMON37583niversiteit Maastricht90
尚未招募
Unknown
Examination of the effect of diets on the gut microbial metatranscriptomeJPRN-UMIN000048871Otsuka Pharmaceutical Co., Ltd.20
已完成
不适用
Beneficial effects of cholesterol absorption inhibitor,ezetimibe on impaired endothelial function in patients with metabolic syndrome.Metabolic syndromeJPRN-UMIN000001305Tohoku University Graduate School of Medicine EZET-trial group60
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease HypercholesterolemiaJPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
Unknown
2 期
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz SyndromeSmith-Lemli-Opitz SyndromeNCT00004347National Center for Research Resources (NCRR)5